TECLISTAMAB

UNII:	54534MX6Z9
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	TECLISTAMAB
GSRS Full Record:	54534MX6Z9 i

2119595-80-9
Immunoglobulin G4 [233-proline, 239-alanine, 240-alanine, 410-leucine], anti- (human CD3 antigen) (human monoclonal JNJ-63483043 γ4-chain), disulfide with human monoclonal JNJ-63483043 λ-chain,(231→227'),(234→230')- bis(disulfide) with immunoglobulin G4 [229-proline, 235-alanine, 236-alanine, 410-arginine] anti-(human tumor necrosis factor receptor superfamily protein TNFRSF17) (human monoclonalJNJ-63705473 γ4-chain) disulfide with human monoclonal JNJ-63705473 λ-chain
JNJ-64007957
TECLISTAMAB [USAN]
TECVAYLI
Teclistamab
Teclistamab [MI]
Teclistamab [WHO-DD]
Teclistamab cqyv [WHO-DD]
Teclistamab-CQYV
immunoglobulin G4-lambda, anti-[Homo sapiens TNFRSF17 (TNF receptor superfamily member 17, tumor necrosis factor receptor superfamily, member 17, B cell maturation antigen, BCMA, BCM, TNFRSF13A, CD269)] and anti-[Homo sapiens CD3 epsilon (CD3E, Leu-4)], monoclonal antibody, bispecific; gamma4 heavy chain anti-TNFRSF17 (1-448) [VH (Homo sapiens IGHV4-39*01 (97.0%) -(IGHD) -IGHJ4*01 (100%)) [10.7.13] (1-121) -Homo sapiens IGHG4*01, nG4m(a) CH2 L92, G4v5 h P10, G4v4 CH2 A1.3, A1.2 (CH1 (122-219), hinge S10>P (229) (220-231), CH2 L92 (310), F1.3>A (235), L1.2>A (236) (232-341), CH3 (342-446), CHS (447-448)) (122-448)], (135-213')-disulfide with lambda light chain anti-TNFRSF17 (1'-214') [V-LAMBDA (Homo sapiens IGLV3-21*02 (96.9%) -IGLJ2*01 (100.0%)) [6.3.11] (1'-108') -Homo sapiens IGLC2*01 (99.1%) A43>G (152) (109'-214')]
teclistamab [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

TECLISTAMAB

Synonyms and Mappings

Resources